L'Oreal contributes to animal testing alternative
This article was originally published in The Rose Sheet
Executive Summary
French beauty firm and assay developer Hurel Corporation are in the research and development stage of an in vitro test for potential skin allergic reactions called the "Allergy Test on a Chip." The device is designed as a substitute for the animal test known as the local lymph node assay, currently accepted by regulatory agencies as a standard means of evaluating potential responses. The test comprises reconstructed human skin, a cell culture capable of stimulating a human immune system response and a means of signaling an immune system response from the skin, the firms say. The collaboration has already hit its first milestone: demonstrating the microfluidic signaling component of the device. If globally adopted, Allergy Test on a Chip "may dramatically reduce the use of animal tests in safety evaluation," the companies say, adding it also has commercial potential
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.